Michael Thiele
6PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 27, 2024
Integrating In Silico and In Vitro Tools for Optimized Antibody Development-Design of Therapeutic Anti-oxMIF Antibodies.Gregor Rossmueller, Irina Mirkina, Michael Thiele
|Oct 07, 2024
Targeting of oxidized Macrophage Migration Inhibitory Factor (oxMIF) with antibody ON104 attenuates the severity of glomerulonephritis.Maroua Ferhat, Julia Mayer, Lyndon H Costa
|Jul 04, 2024
Pretargeted Radioimmunotherapy with the Novel Anti-oxMIF/HSG Bispecific Antibody ON105 Results in Significant Tumor Regression in Murine Models of Cancer.Alejandro A Puchol Tarazona, Alexander Schinagl, Irina Mirkina
|Jun 04, 2024
Pretargeted Radioimmunotherapy with the Novel Anti-oxMIF/HSG Bispecific Antibody ON105 Results in Significant Tumor Regression in Murine Models of Cancer.Alejandro A Puchol Tarazona, Alexander Schinagl, Irina Mirkina
|Apr 17, 2023
Preclinical Evaluation of ON203, A Novel Bioengineered mAb Targeting Oxidized Macrophage Migration Inhibitory Factor as an Anticancer Therapeutic.Gregor Rossmueller, Irina Mirkina, Barbara Maurer
|Feb 08, 2018
Role of the Cysteine 81 Residue of Macrophage Migration Inhibitory Factor as a Molecular Redox Switch.Alexander Schinagl, Randolf J Kerschbaumer, Nicolas Sabarth
Pageof 1
Frequent Collaborators
5 joint publications
Alexander Schinagl
4 joint publications
Gregor Rossmueller
4 joint publications
Irina Mirkina
3 joint publications
Randolf J Kerschbaumer
3 joint publications
Alejandro Puchol Tarazona
2 joint publications
Friedmund Bachmann
1 joint publications
Barbara Maurer
1 joint publications
Verena Hoeld
1 joint publications
Julia Mayer
1 joint publications
Maroua Ferhat
